International audienceIn animal models, tissue stem cells were proposed to exhibit an unexpected level of plasticity, although issues on cell fusions have lead to some controversies. Only transplantation experiments using genetically distinct recipients and donors can unequivocally show these changes in cell fate. We have analyzed oral squamous cell carcinomas arising in 8 long-term survivors of allogeneic bone marrow transplantation, in whom chronic graft-versus-host disease greatly favors development of squamous cell carcinomas, possibly as a consequence of lichenoid mucosal inflammation. With the use of 2 independent methods, (1) combined immunostaining and fluorescent in situ hybridization (FISH) analysis for X and Y chromosomes sequenc...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans results in true biological ...
We hypothesized that chronic tissue stress due to interaction of alloreactive donor cells with host ...
Graft-versus-host disease (GVHD) is a major risk factor for secondary malignancy after hematopoietic...
International audienceIn animal models, tissue stem cells were proposed to exhibit an unexpected lev...
This study characterized the contribution of bone marrow-derived cells to human neoplasia and the pe...
Tumor cell fusion with motile bone marrow-derived cells (BMDCs) has long been posited as a mechanism...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
<label>BACKGROUND</label>Tumor cell fusion with motile bone marrow-derived cells (BMDCs) has long be...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
We analyzed five women, who have developed epithelial neoplasms after sex-mismatched stem cell trans...
Copyright © 2009 AlphaMed PressThis study characterized the contribution of bone marrow-derived cell...
Epithelial cancers can arise from BM-derived cells (BMCs) in animal models. We studied whether the s...
Haematopoietic stem cell transplantation (HSCT) is curative therapy for many malignant and non-mali...
The identification and characterization of cancer stem cells (CSCs) is imperative to understanding t...
Bone marrow-derived mesenchymal stem cells (MSC) have the ability to differentiate into a variety of...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans results in true biological ...
We hypothesized that chronic tissue stress due to interaction of alloreactive donor cells with host ...
Graft-versus-host disease (GVHD) is a major risk factor for secondary malignancy after hematopoietic...
International audienceIn animal models, tissue stem cells were proposed to exhibit an unexpected lev...
This study characterized the contribution of bone marrow-derived cells to human neoplasia and the pe...
Tumor cell fusion with motile bone marrow-derived cells (BMDCs) has long been posited as a mechanism...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
<label>BACKGROUND</label>Tumor cell fusion with motile bone marrow-derived cells (BMDCs) has long be...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans, following hematoablative t...
We analyzed five women, who have developed epithelial neoplasms after sex-mismatched stem cell trans...
Copyright © 2009 AlphaMed PressThis study characterized the contribution of bone marrow-derived cell...
Epithelial cancers can arise from BM-derived cells (BMCs) in animal models. We studied whether the s...
Haematopoietic stem cell transplantation (HSCT) is curative therapy for many malignant and non-mali...
The identification and characterization of cancer stem cells (CSCs) is imperative to understanding t...
Bone marrow-derived mesenchymal stem cells (MSC) have the ability to differentiate into a variety of...
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in humans results in true biological ...
We hypothesized that chronic tissue stress due to interaction of alloreactive donor cells with host ...
Graft-versus-host disease (GVHD) is a major risk factor for secondary malignancy after hematopoietic...